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The impact of gender on outcome after
infrainguinal arterial reconstructions for peripheral
occlusive disease
Enzo Ballotta, MD, Mario Gruppo, MD, Renata Lorenzetti, MD, Giacomo Piatto, MD,
Giuseppe DaGiau, MD, and Antonio Toniato, MD, Padova, Italy
Objective: The role of gender on the outcome of infrainguinal arterial revascularization (IAR) for peripheral arterial
occlusive disease remains uncertain. This study analyzed the outcome of IARs performed over 15 years, stratifying the
results by sex.
Methods: Details of consecutive patients undergoing primary IAR for peripheral arterial occlusive disease from 1995 to
2009 at our institution were prospectively stored in a vascular registry. Demographics, risk factors, indications for
surgery, inflow sources, outflow target vessels, types of conduit, and adverse outcomes were analyzed. Postoperative
surveillance included clinical examination supplemented with duplex scans and ankle-brachial index measurements in all
patients at discharge, 30 days, 6 months, and every 6months thereafter. End points of the study, ie, patency, limb salvage,
and survival rates, were assessed using Kaplan-Meier life-table analysis. The 2 or Fisher exact, Student t, and log-rank
tests were used to establish statistical significance.
Results:Our sample consisted of 1459 IARs performed in 1333 patients, comprising 496women (37.2%; 531 IARs), who
were a mean 3 years older than the men (74 vs 71 years; P < .001) and had a higher incidence of diabetes mellitus (52%
vs 46%; P  .03) and surgery for limb salvage (91% vs 87%; P  .02). An autogenous vein conduit (great or small
saphenous, or both, spliced, arm, or composite veins) was used in 87% of the IARs. No deaths occurred perioperatively
(30 days). The major and minor complication rates were comparable between men and women. At 10 years, the primary
patency rate was 47% in women vs 49% in men (P  .67), the assisted primary patency rate was, respectively, 53% vs 50%
(P .69), the secondary patency rate was 61% vs 61% (P .66), limb salvage rate was 93% vs 91% (P .54), and survival
rate was 43% vs 49% (P  .65). Stratifying by type of conduit revealed no differences in patency or limb salvage rates.
Conclusions: Despite an older age and more advanced stages of disease on presentation in women, IAR performed in
women can achieve patency and limb salvage rates statistically no different from those recorded in their male counterparts,
supporting the conviction that sex per se does not influence the outcome of lower extremity revascularization. (J Vasc
Surg 2012;56:343-52.)
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wThe incidence of peripheral arterial occlusive disease
(PAD) is rising, along with the increase in life expectancy
and the prevalence of atherosclerosis, and is responsible for
high cardiovascular morbidity and mortality rates.1 Women
have generally been assumed to have a lower prevalence of
PAD than men, and this may be true to some extent for
women before or early into menopause, probably related to
the “atheroprotective” effects of hormonal and metabolic
factors in premenopausal women, although the mecha-
nisms behind them are not well understood.2,3 PAD in
women increases significantly during and after menopause,
however, and its incidence in women and men in their 6th
and 7th decades is virtually identical.4 Recent community-
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doi:10.1016/j.jvs.2012.01.040ased surveys have even reported higher rates of PAD in
omen than in men.5,6
Several large studies have shown that (1) increasing
roportions of patients treated for PAD are women, (2)
omen are more likely to be older at presentation, and (3)
omen undergoing infrainguinal arterial reconstruction
IAR) tend to have more advanced disease than their male
ounterparts.7,8 The numerous studies on the outcome of
AR in women and men have reported conflicting data and
idely varied conclusions about this issue:
● Some authors found no significant differences between
women and men in long-term IAR patency7-12 and
limb salvage rates,9,11-15 whereas others identified
worse long-term IAR patency rates for women as a
whole7,13,15,16 or in a subset of IARs to the tibial
vessels.14
● Perioperative mortality did not differ between women
and men in most studies,8-13 but rates for myocardial
infarction (MI) or wound complications were signifi-
cantly higher for women in all series reporting morbid-
ity.8,10-12,14
● Many studies found no differences in long-term sur-
vival between women and men,7-9,12,14,15 but others
reported worse long-term survival rates in women,
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August 2012344 Ballotta et alwith statistically significant differences, especially for
women with diabetes mellitus (DM).10,13
In the light of such evidence, it has been hard to draw
any final conclusions on the effect of sex on the outcome of
IAR. Our question was whether women with infrainguinal
disease have worse outcomes in patency, limb salvage, and
long-term survival rates than their male counterparts after
IAR. This study aims to address this question.
METHODS
Details of all consecutive patients undergoing primary
IAR at our institution between 1995 and 2009 for PAD
were prospectively stored in a vascular registry. The data
included patient demographics, risk factors, indication for
revascularization, inflow source, outflow target vessel, type
of conduit, and adverse outcomes.
All patients had an electrocardiogram, and any history
of MI, congestive heart failure, or angina, was recorded. If
clinical history and electrocardiogram findings were nor-
mal, no further work-up was undertaken; if either were
abnormal, echocardiogram or dipyridamole thallium scan,
or both, were obtained at our consultant cardiologist’s
discretion. All patients underwent preoperative standard
biplanar arteriography, magnetic resonance angiography,
or computed tomography angiography (CTA), or a com-
bination of these methods, to confirm the clinical and
vascular laboratory diagnosis of PAD, as determined by
arterial mapping with duplex ultrasound imaging and mea-
surement of the ankle-brachial index (ABI), and to plan
surgery. All patients with foot lesions were treated accord-
ing to a standard protocol.17
Surgical technique. Revascularizations were com-
pleted using a single-team approach for arterial dissection
and vein harvesting when an autologous vein was used. The
preferred conduit was the great saphenous vein (GSV),
which was harvested whenever this seemed feasible on the
strength of venous mapping by duplex scan (subject to
direct assessment at surgery). The reversed GSV bypass was
the preferred procedure, exclusively for a personal choice of
the surgeon. When the ipsilateral or contralateral GSV was
unsuitable or not wholly available, and spliced veins (great/
small saphenous vein and arm vein) were also unavailable,
then a 7- or 8-mm thin-walled expanded polytetrafluoreth-
ylene (PTFE) graft (Gore-Tex; W. L. Gore and Associates,
Flagstaff, Ariz) was used. Short bypass revascularizations
were performed when the surgeon found the superficial
femoral artery or the popliteal artery was adequate for
inflow (confirming preoperative angiographic findings).
The selected inflow artery was exposed in standard fashion.
The distal exposure methods varied, depending on the
vessel chosen for the bypass procedure. The inframalleolar
vessels include the posterior tibial artery, at or below the
medial malleolus, the dorsalis pedis artery, and the pedal
branch arteries, defined as any tarsal, plantar, or anterior
lateral malleolar artery.18 The peroneal artery was always
exposed using a lateral approach requiring segmental fibu-
lectomy.19 The dorsalis pedis artery was often chosen as the autflow target artery as an alternative to a patent peroneal
rtery and when no tibial vessels were in direct continuity
ith the foot. Revascularization to the dorsalis pedis artery
as avoided in cases of severe dorsal foot infection.
All distal anastomotic sites below the knee underwent
tandard vein patch angioplasty no longer than 3 cm, as
escribed elsewhere.20 The vein for the patch was harvested
rom any available site, including saphenous vein remnants,
rm veins harvested under local anesthesia, and occasionally
aphenous vein collaterals. When the anterior tibial artery
r the peroneal artery were used as the outflow vessel, the
ein graft was always routed through the interosseous
embrane but was routed in the standard fashion when the
osterior tibial artery was used.
All revascularizations were performed with the patient
nder regional anesthesia (epidural or spinal). No intraop-
rative contrast or duplex scan arteriography was per-
ormed. Intravenous heparin (5000 IU) was administered
efore clamping and was not reversed with protamine.
eparin infusion was started 6 to 10 hours postoperatively,
ith oral warfarin (Coumadin; Du Pont De Nemours,
ilmington, Del) administered on the first postoperative
ay. Long-term anticoagulation treatment with Coumadin
as continued for 6 months, aiming for a normalized ratio
f between 2 and 3 in most of the patients. After 6 months,
25 mg aspirin was taken daily.
Postoperative surveillance. End points of the study
ere primary patency, assisted primary patency, secondary
atency, limb salvage, and long-term survival rates. Postop-
rative surveillance included clinical examinations, supple-
ented with duplex scans and ABI measurements at dis-
harge, 30 days, 6 months, and every 6 months thereafter.
ollow-up always included a color duplex investigation of
he inflow artery, the whole conduit, both anastomoses,
nd the initial tract of the outflow artery. Graft patency was
ssessed from the presence of a palpable distal pulse, ABI
easurement, or a patent graft on duplex scan. A drop in
he ABI of 0.15 compared with the initial postoperative
ndex was assumed to indicate a failing graft. A duplex
ltrasound scan was indicative of a significant lesion along
he graft if the peak systolic velocity was 300 cm/s and
he velocity ratio was 3.0, whereas the absence of any
olor flow in the graft was indicative of occlusion. Graft
tenoses discovered by duplex scan were confirmed by
rteriography or CTA and electively repaired if the diame-
er reduction was 50%, judging from the image.
After surgery, patients were seen as often as necessary
ntil their wound healed completely. The wound-healing
rocess was assessed in terms of wound-related complica-
ions (ie, the need for hospital readmission or repeat sur-
ery, or additional wound-related treatment such as antibi-
tics or a visiting nurse) and the time it took for the wound
o heal. The healing times for surgical incisions and for
schemic wounds requiring arterial reconstruction were
ecorded separately. The total ischemic wound-healing
ime included secondary procedures needed to treat isch-
mic ulcers or gangrene, including debridement or toe
mputation. Minor toe and foot amputations or debride-
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Volume 56, Number 2 Ballotta et al 345ment performed after the arterial reconstruction to com-
plete the treatment of the original ischemic lesions were
considered as part of the primary operation rather than as
redo surgery. All the criteria used for this analysis aimed to
conform to the standards suggested by the Ad Hoc Com-
mittee of the Joint Council of Vascular Societies for Re-
ports Dealing with Lower Extremity Ischemia.21
Statistical analysis. Continuous data were compared
with the Student t-test. Frequencies and categoric data
were compared with a 2 or Fisher exact test, as appropri-
ate. The primary patency, assisted primary patency, second-
ary patency, limb salvage, and long-term survival rates were
assessed by Kaplan-Meier analysis, and curves were com-
pared using the Mantel-Cox log-rank test. A Cox propor-
tional hazard analysis was used to determine which factors
with statistical or marginal significance at univariate analysis
could influence outcomes, calculating the odds ratio (OR)
with 95% confidence intervals (CIs). All tests were two-
tailed, and statistical significance was inferred at value of
P  .05. Because each perioperative and late outcome was
correlated with the surgical procedure, and patients who
underwent bilateral IAR were exposed to twice the risk of
graft failure or limb loss, several data items were analyzed
vis-à-vis surgical procedures instead of patients.
RESULTS
During a 15-year period, 1459 IARs were performed in
1333 patients at our institution, comprising 531 IARs in
496 women (37.2%; group I) and 928 IARs in 837 men
(group II). Staged bilateral IARs were performed in 126
patients (35 in group I). An additional 45 patients referred
to our center who were mentally impaired (n 34) or had
Table I. Demographics, risk factors, and comorbidities
Variablea Total
IARs 1459 (100)
Patients 1333 (100)
Age, years
Diabetes mellitus 647 (48.5)
Hyperlipemia 810 (60.7)
Hypertension 870 (65.2)
Smoking historyb 713 (53.5)
Chronic kidney diseasec 145 (10.8)
Cardiac disease 683 (51.2)
Prior intervention
PTA stenting/CABG 266 (19.9)
Inflow procedures 220 (16.5)
History of
Myocardial infarction 368 (27.6)
Pulmonary disease 224 (16.8)
Stroke 146 (10.9)
ABI measurement
In claudication
In critical limb ischemia
ABI, Ankle-brachial index; CABG, coronary artery bypass grafting; IAR, inf
aContinuous data are shown as the mean  standard deviation and categor
bCurrent tobacco use or cessation within the last 5 years.
cDefined as creatinine 2.0 mg/dL.a life expectancy of1 year (n 11), who were bedridden cr nonambulatory, and 19 patients with ischemic soft tissue
reakdown between the calcaneus and metatarsal heads
plantar region) were not considered for arterial recon-
tructive surgery. These 45 patients had necrotic ulcers or
angrene and 33 required primary amputation to treat their
isease; the other 12 underwent a major amputation gen-
rally 30 days after a percutaneous intervention had
ailed. Among the 19 patients with extensive tissue loss in
he plantar region, 13 underwent early (30 days) and six
elayed major amputation after a primary percutaneous
ntervention had failed.
Table I summarizes demographics, risk factors, comor-
idities, and other variables in both groups. The women
ere significantly older than the men at presentation (74
.4 vs 71  6.8; P  .001) and were more likely to have
M (52.2% vs 46.3%; P  .03), whereas the men more
ommonly had a history of smoking (59.1% vs 43.9%; P 
001), arterial hypertension (67.7% vs 61.1%; P .01), and
rior inflow procedures (18.5% vs 13.5%; P  .01). There
ere no differences between the two groups in the other
Group I Group II P
531 (36.4) 928 (63.6)
496 (37.2) 837 (62.8)
74  5.4 71  6.8 .001
259 (52.2) 388 (46.3) .03
287 (57.8) 523 (62.5) .10
303 (61.1) 567 (67.7) .01
218 (43.9) 495 (59.1) .001
46 (9.2) 99 (11.8) .14
239 (48.2) 444 (53.0) .09
91 (18.3) 175 (20.9) .26
65 (13.1) 155 (18.5) .01
132 (26.6) 236 (28.2) .53
80 (16.1) 144 (17.2) .61
49 (9.9) 97 (11.6) .33
0.75  0.27 0.77  0.19 .09
0.42  0.29 0.45  0.33 .07
inal arterial revascularization; PTA, percutaneous transluminal angioplasty.
as number (%).
able II. Indication for infrainguinal arterial
econstruction
ndication
Total
No. (%)
Group I
No. (%)
Group II
No. (%) P
laudication 168 (11.5) 48 (9.1) 120 (12.9) .02
ritical limb ischemia 1291 (88.5) 483 (90.9) 808 (87.1) .02
Rest pain 455 (31.2) 179 (33.7) 276 (29.7) .11
Nonhealing ulcer 509 (34.9) 198 (37.3) 311 (33.5) .14
Gangrene 327 (22.4) 106 (19.9) 221 (23.8) .09raingu
ic dataonsidered variables (Table I). The most common indica-
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August 2012346 Ballotta et altion for surgery (Table II) was critical limb ischemia (CLI,
90.9% in group I vs 87.1% in group II; P  .02) in the
subset of rest pain (33.7% vs 29.7%; P  .11), nonhealing
ulcer (37.3 vs 33.5%; P  .14), or gangrene (19.9% vs
23.8%; P .09). In both groups, the most common inflow
sources were the common femoral artery and the superficial
femoral artery/above-knee popliteal artery (51.9% and
16.2%, respectively, in group I; 49.2% and 17.4% in group
II). The tibial arteries were the more often used target
outflow vessels in group I (34.1%) and group II (37.9%;
Table III). The reversed autogenous GSV was the preferred
graft for revascularization in 81.5% of women and in 78.7%
of men. There was no difference between the sexes in the
use of in situ or spliced veins or in composite or prosthetic
conduits (Table III).
Perioperative mortality and morbidity data. A de-
tailed list of the perioperative outcomes is given in Table
IV. There were no perioperative deaths. The overall rates
for systemic and minor complications, additional local pro-
cedures, and minor amputations were comparable between
the two groups. No differences emerged between groups I
and II in improvement in the postoperative ABI measure-
ments.
Long-term outcomes. Of the 1333 patients alive 30
days after IAR, 38 (2.8%, 38 IARs) were lost to follow-up.
The follow-up was therefore completed by 1295 patients
(97.2%, 1421 IARs), of which 484 were women (519
IARs). The median follow-up was 6.1 years in group I
(mean, 7 2.2; range, 0.1-15 years) and 6.4 years in group
Table III. Inflow sources, outflow target vessel, type of co
Variable
Total
No. (%)
Inflow sources
Iliac/graft 217 (14.8)
Common femoral artery 733 (50.2)
Deep femoral artery 78 (5.3)
Distal SFA/AK popliteal 248 (17.0)
BK popliteal 125 (8.5)
TPT/tibial 58 (3.9)
Outflow vessel target
AK popliteal 365 (25.0)
BK popliteal/TPT 360 (24.6)
Tibial 533 (36.5)
Proximal third 269 (18.4)
Midthird 106 (7.2)
Distal third 158 (10.8)
Inframalleolar artery 201 (13.8)
Bypass procedure conduit
Reversed autogenous GSV 1163 (79.7)
In situ 24 (1.6)
Spliced vein (GSV, SSV, arm) 39 (2.6)
Composite (vein/PTFE) 46 (3.1)
PTFE 187 (12.8)
Preoperative foot care
Drainage 162 (11.1)
Debridement 211 (14.4)
AK, Above the knee; BK, below the knee; GSV, great saphenous vein; PTF
vein; TPT, tibial-peroneal trunk.II (mean, 7.2  2.6; range, 0.1-15 years). 6To establish whether prosthetic graft revasculariza-
ions might influence the technical outcome, we strati-
ed the two groups by vein vs prosthetic grafts. Figs 1-4
how details of Kaplan-Meier life-table analyses of the
rimary patency, assisted primary patency, secondary
atency, and limb salvage rates for groups I and II, as a
hole and after stratifying patients by type of conduit.
At 5 and 10 years, the overall primary patency rates
ere, respectively, 68% and 47% in women and 71% and
9% in men (log-rank test, P  .67; Fig 1), with no
ignificant difference between the two groups for vein
rafts (70% and 50% vs 73% and 51%; log-rank test, P 
64) or prosthetic grafts (42% and 21% vs 46% and 19%;
og-rank test, P  .71).
At 5 and 10 years, the overall assisted primary patency
ates were, respectively, 76% and 53% in women and 77%
nd 50% in men (log-rank test, P  .69; Fig 2), with no
ignificant difference between the two groups for vein
rafts (77% and 55% vs 79% and 51%; log-rank test, P 
64) or prosthetic grafts (61% and 30% vs 70% and 35%;
og-rank test, P  .96). All involved lesions were detected
n duplex imaging and were usually intrinsic defects
qually distributed along the length of the failing but still
atent graft. Graft revisions mainly involved thrombectomy
r lysis, or both, percutaneous vein graft dilation, and patch
ngioplasty.
At 5 and 10 years, the overall secondary patency rates
ere, respectively, 83% and 61% in women and 83% and
it, and preoperative foot procedures
Group I
No. (%)
Group II
No. (%) P
75 (14.1) 142 (15.3) .54
276 (51.9) 457 (49.2) .31
29 (5.4) 49 (5.2) .88
86 (16.2) 162 (17.4) .53
48 (9.0) 77 (8.3) .62
17 (3.2) 41 (4.4) .25
141 (26.5) 224 (24.1) .30
141 (26.5) 219 (23.6) .20
181 (34.1) 352 (37.9) .14
94 (17.7) 175 (18.8) .58
35 (6.6) 71 (7.6) .45
52 (9.8) 106 (11.4) .33
68 (12.8) 133 (14.3) .41
433 (81.5) 730 (78.7) .18
7 (1.3) 17 (1.8) .45
12 (2.2) 27 (2.9) .46
17 (3.2) 29 (3.1) .93
62 (11.6) 125 (13.4) .32
51 (9.6) 111 (11.9) .17
66 (12.4) 145 (15.6) .09
ytetrafluoroethylene; SFA, superficial femoral artery; SSV, small saphenousndu
E, pol1% in men (log-rank test, P  .66; Fig 3), with no
Categoric data are shown as number (%) and continuous data are shown as the mean  standard deviation.
bValue derived by the Fisher exact test.
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Volume 56, Number 2 Ballotta et al 347Fig 1. Kaplan-Meier life-table analysis shows the primary patency rate for women and men in the series as a whole
(odds ratio [OR], 1.04; 95% confidence interval [CI], 0.83-1.33; log-rank test, P .67) and in patients with a vein graft
(OR, 1.05; 95% CI, 0.81-1.38; log-rank test, P .64) or with a polytetrafluoroethylene (PTFE) graft (OR, 1.11; 95%
CI, 0.62-2.01; log-rank test, P .71). The raw number of the limbs at risk and the standard error (SE) analyzed for eachTable IV. Perioperative (30-day) outcomes
Outcomea Total Group I Group II P
Death 0 0 0
Major amputation 22 (1.5) 6 (1.1) 16 (1.7) .37
Systemic complications 202 (13.8) 68 (12.8) 134 (14.4) .38
Nonfatal MI 36 (2.5) 18 (3.4) 18 (1.9) .08
Renal failure 26 (1.7) 10 (1.8) 16 (1.7) .82
Pneumonia 53 (3.6) 15 (2.8) 38 (4.1) .21
Arrhythmia 87 (5.9) 25 (4.7) 62 (6.7) .12
Minor complications 112 (7.6) 46 (8.6) 66 (7.1) .28
Wound hematoma/dehiscence 44 (3.0) 21 (3.9) 23 (2.4) .11
Inguinal lymphocele 63 (4.3) 24 (4.5) 39 (4.2) .77
Wound infection 5 (0.3) 1 (0.2) 4 (0.4) .44b
Graft infection 0 0
Additional local procedures 273 (18.7) 96 (18.0) 177 (19.0) .63
Drainage 60 (4.1) 25 (4.7) 35 (3.7) .38
Debridement 213 (14.5) 71 (13.3) 142 (15.3) .31
Minor amputations 326 (22.3) 105 (19.7) 221 (23.8) .08
Toe(s), ray(s) 239 (16.3) 81 (15.2) 158 (17.0) .37
Transmetatarsal 87 (5.9) 24 (4.5) 63 (6.7) .08
ABI measurement
In claudication 0.95  0.36 0.96  0.22 .50
In critical limb ischemia 0.82  0.17 0.83  0.13 .20
ABI, Ankle-brachial index; MI, myocardial infarction.
ainterval are shown for each subgroup.
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August 2012348 Ballotta et alsignificant difference between the two groups for vein
grafts (84% and 62% vs 83% and 62%; log-rank test, P 
.56) or for prosthetic grafts (69% and 34% vs 80% and 36%;
log-rank test, P .70). In most of the grafts that failed, this
was due to outflow or inflow disease secondary to myointi-
mal proliferation and hyperplasia or to the progression of
atherosclerotic lesions. Graft patency was restored with
thrombectomy/lysis, until satisfactory runoff was ob-
served, and distal extension of the revascularization with a
“jump” vein graft in the cases of outflow disease or with
thrombectomy/lysis and revision (proximal graft exten-
sion) in the cases of inflow disease. Some failed IARs
were simply thrombectomized or lysed, providing there
was no underlying anatomic defect or no atherosclerotic
disease adjacent to the graft responsible for graft failure,
which was presumably related to a decrease in blood flow
in a poor runoff bed.
Overall, 96 major amputations were performed (23%
during the perioperative period), with no significant differ-
ence between groups I and II (5.9% vs 7.2%; P .37), even
after stratifying the groups by vein (5.6% vs 6.9%; P .35)
or PTFE graft conduit (9.2% vs 9.0%; P  .95). No major
Fig 2. Kaplan-Meier life-table analysis shows the assiste
whole (odds ratio [OR], 1.05; 95% confidence interval [
vein graft (log-rank test, P  .64; OR, 1.06; 95% CI, 0.7
1.02; 95% CI, 0.44-2.34; log-rank test, P  .96). The ra
analyzed for each interval are shown for each subgroup.amputations were necessary during follow-up of IARs that eere above the knee. Seventeen (17.7%) major amputa-
ions were needed for persistent foot infections or osteo-
yelitis, or both, despite a patent graft. Although the major
mputation rate was higher in diabetic patients (8.5% vs
.9%), the difference failed to reach significance (P  .07),
nd there was no statistically significant difference between
emale and male diabetic patients (8.5% vs 8.2%; P .99) or
etween female and male nondiabetic patients (3.8% vs
.1%; P  .08).
At 5 and 10 years, the overall limb salvage rates were,
espectively, 93% and 93% in women and 92% and 91% in
en (log-rank test, P  .54; Fig 4), with no significant
ifference between the two groups for vein grafts (93% and
3% vs 92% and 92%; log-rank test, P  .48) or for
rosthetic grafts (77% and 77% vs 81% and 81%; log-rank
est, P  .64).
At 5 and 10 years, patient survival rates were, respec-
ively, 64% and 43% in women and 62% and 49% in men
log-rank test, P .65). The main known cause of death in
oth groups was cardiac disease.
All potentially prognostic variables, including age, sex,
M, smoking, hypertension, hyperlipidemia, cardiac dis-
mary patency rate for women and men in the series as a
.80-1.39; log-rank test, P  .69) and in patients with a
4) or with a polytetrafluoroethylene (PTFE) graft (OR,
mber of the patients at risk and the standard error (SE)d pri
CI], 0
9-1.4
w nuase, prior MI or cardiac surgery, prior stroke or inflow
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Volume 56, Number 2 Ballotta et al 349procedures, inflow source and target outflow vessel, and
type of conduit, were submitted to univariate analysis as
potential predictors of revascularization failure or limb loss.
None of these variables influenced the patency or limb
salvage rates in either group.
DISCUSSION
The results of IAR for PAD are often difficult to analyze
because a multitude of variables may significantly influence
the outcome, including (1) different baseline characteristics
due to concomitant risk factors and comorbidities, (2)
indications for surgery (claudication or CLI), (3) the site of
the outflow target artery (above or below the knee popliteal
artery, or tibial vessels), and (4) the type and quality of the
conduit used (vein or prosthetic graft). Even the role of sex
on the outcome of IAR remains hard to establish.
The findings of the present study indicate that female
patients can undergo IAR for PAD with patency and limb
salvage rates that are statistically no different from those
seen in their male counterparts, supporting the conviction
that sex per se does not influence the outcome of lower
extremity revascularization. The women in our series were
significantly older than the men at the time of surgery and
Fig 3. Kaplan-Meier life-table analysis shows the second
(odds ratio [OR], 1.07; 95% confidence interval [CI], 0.7
(OR, 1.10; 95% CI, 0.78-1.58; log-rank test, P .56) or
CI, 0.31-2.20; log-rank test, P .70). The raw number
each interval are shown for each subgroup.had a higher incidence of DM (both these findings are not eew in the medical literature8,9,14,22), whereas the men
ere more often past or present smokers and were more
ikely to have arterial hypertension and a history of prior
nflow procedures. No other significant differences
merged between the two groups in risk factors and comor-
idities, but prevalence of CLI was higher among women,
einforcing the impression that women are more likely to
e referred at an older age than men and treated at a more
dvanced stage of ischemia.8,23,24 The reasons for this are
ikely multifactorial and may include, as suggested in some
eports, social isolation, more limited access to care due to
nancial reasons, and PAD symptoms being mistaken for
steoporosis or arthritis, which are common in such pa-
ients.23,25
Although 50% of our patients had cardiac disease on
resentation, with a high incidence of prior MI and percu-
aneous transluminal angioplasty/stenting or coronary ar-
ery bypass grafting, both in the series as a whole and in
ach group, the overall rate of perioperative nonfatal MI
as only 2.5%, with a higher prevalence among women,
hough the difference did not reach significance (3.4% vs
.9%; P  .08). A higher frequency of (even fatal) periop-
rative MI in women was also reported in other analyses,
atency rate for women and men in the series as a whole
0; log-rank test, P .66) and in patients with a vein graft
a polytetrafluoroethylene (PTFE) graft (OR, 0.82; 95%
patients at risk and the standard error (SE) analyzed forary p
7-1.5
with
of theven though men revealed paradoxically more cardiac dis-
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explain why more women had latent cardiac disease going
undetected on routine preoperative screening and ad-
versely affecting them postoperatively.10,26
Overall, there were no perioperative deaths in our
series, a finding never previously reported. Indeed, all other
studies recorded overall perioperative mortality rates of 1%
to 5%, usually with no differences between women and
men.8-16 Unfortunately, we have no objective data for
explaining our remarkable finding, although regional anes-
thesia (all of our patients underwent epidural or spinal
anesthesia, thus minimizing the risk of postoperative major
adverse events) and a relatively quick surgical procedure
could have also played an important part in this outcome.
Although we might expect the women’s more ad-
vanced disease at presentation to coincide with technical
worse outcomes, this was not true of our sample: female
patients fared just as well as their male counterparts in IAR
patency and limb salvage rates, even after stratifying by type
of conduit. These findings are consistent with other reports
on the effect of sex on conventional technical outcome
measures,7-12 but are in contrast with the worse long-term
patency rates often identified in women,7,13,15,16 which
have been attributed, for instance, to increased risk factors,
Fig 4. Kaplan-Meier life-table analysis shows the limb s
0.87; 95% CI, 0.57-1.33; log-rank test, P  .54) and i
log-rank test, P .48) or with polytetrafluoroethylene (P
.64). The raw number of the patients at risk and the stan
subgroup.such as smoking, DM, older age, and cardiovascular dis- aase, different medical comorbidities, smaller arteries, or
ate treatment, at more advanced stages of disease.7,13-16
nlike an earlier analysis that identified different patency
ates at tibial level,14 but consistently with other authors,8
e found that performing IARs with tibial arteries as target
utflow vessels did not significantly affect the long-term
atency and limb salvage rates in our two groups and
ubgroups, confirming previous findings of ours reported
lsewhere.17,19,20 Adopting an intensive postoperative pro-
ocol of graft surveillance led to many prophylactic lesion
evisions being performed successfully in both sexes, ex-
laining the marked improvement in the patency rates for
ailing (assisted primary patency) and failed revasculariza-
ions (secondary patency) at all intervals in both groups.
Further features of our study were that (1) the surgical
echnique involved standard vein patching of all distal
nastomotic sites below the knee and (2) all patients re-
eived anticoagulation therapy in the postoperative period,
egardless of the conduit used. Coumadin therapy has been
escribed as an important factor in improving the patency
ates of bypass prosthetic grafts in patients needing arterial
econstruction to infrapopliteal vessels,27 whereas the long-
erm benefit of anticoagulation after vein IAR remains to be
learly demonstrated.28,29 Because we used both vein patch
e rate for women and men in the series as a whole (OR,
ients with a vein graft (OR, 0.84; 95% CI, 0.53-1.34;
graft (OR, 1.27; 95% CI, 0.42-3.99; log-rank test, P
error (SE) analyzed for each interval are shown for eachalvag
n pat
TFE)
dardngioplasty and anticoagulation therapy in all our IARs, we
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these factors in improving patency rates.
The incidence of limb loss was comparable for our
female and male patients, a finding that correlates well with
the situation reported in most series.8-10,12-15 The type of
conduit did not influence this outcome, probably because
prosthetic grafts were only used in10% of the IARs in our
series. Considering that 88.5% of our population (and
90% of the women) underwent IAR for limb salvage, the
10-year limb salvage rate of 93% in group I and 92% in
group II clearly demonstrates the efficacy of the surgical
procedure. This is important to note, in our opinion,
especially because the role of endovascular procedures in
the treatment of CLI is evolving. Their use, the degree of
enthusiasm for them, and the related results have varied
considerably over time, and now the endovascular ap-
proach has been suggested as the first-line therapy for most
patients with PAD. Percutaneous treatments may be a less
invasive alternative to open surgery, but even though com-
parable patency and limb salvage rates have been reported
in female and male patients in the short-term and medium-
term,30 some concerns remain regarding the long-term
durability of endovascular procedures in this setting.31
This study has several limitations. First, the analysis is
limited naturally by its retrospective nature, even though
the data were collected prospectively.
Second, the female and male patients differed in demo-
graphics, medical comorbidities, and clinical presentation.
They were, however, comparable in the position and extent
of anatomic lesions indirectly localizable by inflow sources
and outflow target vessels, the type of conduit used, and
postoperative foot care procedures, ensuring the technical
homogeneity of the groups and the reliability of the results.
Finally, we acknowledge that our study may have been
conducted on a relatively selected group that was not
representative of the general population with CLI because
it reflects a preliminary selection made by the physicians
referring patients for revascularization at our institution (a
tertiary care center with an interest and expertise in the
management of CLI), who probably chose patients with a
longer life expectancy, while recommending a conservative
treatment (that ultimately leads to a major amputation in
the majority of cases) for patients with multiple comorbidi-
ties and in worse general health.
CONCLUSIONS
IARs in female patients can achieve the same patency
and limb salvage rates as those recorded in their male
counterparts, and although the former may be older at
presentation and need surgery for limb salvage more often
than men, their outcome does not appear to be adversely
affected.The skepticism surrounding the efficacy and dura-
bility of IAR in women appears to be unwarranted.
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